NASDAQ : CMPS
COMPASS Pathways plc — Financial statements
Healthcare · Medical Care Facilities · United Kingdom
Last price 12.19 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.69B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 68.88M | 60.60M | 59.17M | 49.40M | 45.35M | 39.19M |
| Research & Development | 116.81M | 114.69M | 97.94M | 74.64M | 50.63M | 34.38M |
| Operating Expenses | 185.69M | 175.29M | 157.11M | 124.04M | 95.98M | 73.57M |
| Operating Income | -185.69M | -175.29M | -157.11M | -124.04M | -95.98M | -73.57M |
| Interest Expense | -5.19M | -4.52M | -4.48M | -2.20M | ||
| Interest & Investment Income | 9.06M | 7.18M | 8.27M | 4.62M | 4.06M | 40.00K |
| Currency Exchange Gain (Loss) | -2.65M | 3.47M | -1.03M | 3.69M | 821.00K | 1.99M |
| Other Non Operating Income (Expenses) | -212.36M | -121.18M | 823.00K | 255.00K | ||
| EBT Excluding Unusual Items | -396.83M | -290.33M | -153.53M | -117.68M | -91.10M | -71.54M |
| Pretax Income | -396.83M | -290.33M | -153.53M | -117.68M | -91.10M | -71.54M |
| Income Tax Expense | -2.64M | -2.47M | 1.59M | 780.00K | 408.00K | 199.00K |
| Net Income | -394.19M | -287.86M | -155.12M | -118.46M | -91.50M | -71.74M |
| Net Income to Common | -394.19M | -287.86M | -155.12M | -118.46M | -91.50M | -71.74M |
| Shares Outstanding (Basic) | 109.21M | 93.50M | 67.48M | 51.03M | 42.44M | 40.00M |
| Shares Outstanding (Diluted) | 109.21M | 93.50M | 67.48M | 51.03M | 42.44M | 40.00M |
| EPS (Basic) | -3.61 | -3.08 | -2.30 | -2.32 | -2.16 | -1.79 |
| EPS (Diluted) | -3.61 | -3.08 | -2.30 | -2.32 | -2.16 | -1.79 |
| Free Cash Flow | -161.14M | -157.24M | -119.19M | -97.44M | -106.05M | -68.08M |
| Free Cash Flow Per Share | -1.48 | -1.68 | -1.77 | -1.91 | -2.50 | -1.70 |
| EBITDA | -185.56M | -175.07M | -156.88M | -123.80M | -95.65M | -73.40M |
| D&A For EBITDA | 129.00K | 216.00K | 233.00K | 242.00K | 330.00K | 175.00K |
| EBIT | -185.69M | -175.29M | -157.11M | -124.04M | -95.98M | -73.57M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 433.30M | 149.61M | 165.08M | 220.20M | 143.21M | 273.24M |
| Cash & Short-Term Investments | 433.30M | 149.61M | 165.08M | 220.20M | 143.21M | 273.24M |
| Other Receivables | 15.15M | 15.39M | 20.71M | 28.93M | 15.62M | 11.22M |
| Receivables | 15.15M | 15.39M | 20.71M | 28.93M | 15.62M | 11.22M |
| Prepaid Expenses | 1.89M | 2.82M | 3.36M | |||
| Restricted Cash | 425.00K | 379.00K | 389.00K | 440.00K | 175.00K | 104.00K |
| Other Current Assets | 26.80M | 26.12M | 15.11M | 9.84M | 29.83M | 7.38M |
| Total Current Assets | 475.67M | 191.49M | 201.29M | 261.30M | 191.65M | 295.30M |
| Property, Plant & Equipment | 3.94M | 3.42M | 2.01M | 4.73M | 2.62M | 4.09M |
| Long-Term Investments | 469.00K | 469.00K | 525.00K | |||
| Long-Term Deferred Tax Assets | 4.55M | 3.75M | 3.77M | 3.34M | 2.22M | 766.00K |
| Long-Term Deferred Charges | 5.74M | 5.96M | ||||
| Other Long-Term Assets | 20.39M | 11.68M | 858.00K | 202.00K | 327.00K | 213.00K |
| Total Assets | 504.56M | 210.35M | 213.67M | 275.99M | 197.29M | 300.90M |
| Accounts Payable | 12.24M | 15.22M | 12.28M | 5.89M | 4.76M | 2.56M |
| Accrued Expenses | 15.70M | 8.65M | 13.17M | 10.26M | 8.67M | 10.04M |
| Current Portion of Long-Term Debt | 17.52M | 5.51M | ||||
| Current Portion of Leases | 1.89M | 2.11M | 1.73M | 2.41M | 1.51M | 2.23M |
| Other Current Liabilities | 337.46M | 204.28M | 1.32M | 1.04M | 656.00K | 268.00K |
| Total Current Liabilities | 367.29M | 247.79M | 34.02M | 19.60M | 15.60M | 15.11M |
| Long-Term Debt | 50.73M | 14.11M | 24.65M | 28.76M | ||
| Long-Term Leases | 2.02M | 1.29M | 303.00K | 1.88M | 418.00K | 1.38M |
| Total Liabilities | 420.03M | 263.20M | 58.97M | 50.24M | 16.01M | 16.49M |
| Common Stock | 1.40M | 973.00K | 702.00K | 635.00K | 440.00K | 435.00K |
| Additional Paid-In Capital | 1.08B | 783.56M | 704.92M | 621.64M | 458.82M | 444.75M |
| Retained Earnings | -985.19M | -822.59M | -534.73M | -379.61M | -261.15M | -169.64M |
| Comprehensive Income & Other | -14.74M | -14.79M | -16.19M | -16.93M | -16.84M | 8.87M |
| Total Common Equity | 84.53M | -52.85M | 154.69M | 225.74M | 181.28M | 284.41M |
| Shareholders' Equity | 84.53M | -52.85M | 154.69M | 225.74M | 181.28M | 284.41M |
| Total Liabilities & Equity | 504.56M | 210.35M | 213.67M | 275.99M | 197.29M | 300.90M |
| Total Debt | 54.63M | 35.03M | 32.19M | 33.05M | 1.93M | 3.61M |
| Net Cash (Debt) | 378.67M | 114.57M | 132.89M | 187.15M | 141.28M | 269.63M |
| Net Cash Per Share | 3.47 | 1.23 | 1.97 | 3.67 | 3.33 | 6.74 |
| Filing Date Shares Outstanding | 138.48M | 128.92M | 92.67M | 64.23M | 42.76M | 42.02M |
| Total Common Shares Outstanding | 135.72M | 96.09M | 68.55M | 61.94M | 42.63M | 42.02M |
| Working Capital | 108.39M | -56.30M | 167.28M | 241.69M | 176.06M | 280.19M |
| Book Value Per Share | 0.62 | -0.55 | 2.26 | 3.64 | 4.25 | 6.77 |
| Tangible Book Value | 84.53M | -52.85M | 154.69M | 225.74M | 181.28M | 284.41M |
| Tangible Book Value Per Share | 0.62 | -0.55 | 2.26 | 3.64 | 4.25 | 6.77 |
| Machinery | 750.00K | |||||
| Leasehold Improvements | 6.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -394.19M | -287.86M | -155.12M | -118.46M | -91.50M | -71.74M |
| Depreciation & Amortization | 21.00K | 216.00K | 233.00K | 242.00K | 330.00K | 175.00K |
| Loss (Gain) From Sale of Assets | 40.00K | |||||
| Stock-Based Compensation | 12.98M | 13.59M | 19.52M | 17.28M | 13.12M | 8.64M |
| Other Operating Activities | 217.61M | 131.06M | 4.46M | 46.00K | 3.27M | 1.82M |
| Change in Accounts Payable | 1.55M | 2.03M | 6.59M | 864.00K | 2.50M | -163.00K |
| Change in Other Net Operating Assets | 1.16M | -16.31M | 4.45M | 4.28M | -31.46M | -5.60M |
| Operating Cash Flow | -161.14M | -157.24M | -119.19M | -97.38M | -105.45M | -67.75M |
| Capital Expenditures | -66.00K | -596.00K | -334.00K | |||
| Sale of Property, Plant & Equipment | 2.00K | |||||
| Investing Cash Flow | -64.00K | -596.00K | -334.00K | |||
| Long-Term Debt Issued | 29.59M | |||||
| Total Debt Issued | 18.58M | 29.59M | ||||
| Net Debt Issued (Repaid) | 18.58M | 29.59M | ||||
| Issuance of Common Stock | 245.92M | 150.11M | 64.06M | 153.39M | 1.04M | 156.65M |
| Repurchase of Common Stock | -239.00K | -239.00K | -265.00K | |||
| Other Financing Activities | 105.93M | -9.40M | -8.88M | |||
| Financing Cash Flow | 370.20M | 140.71M | 63.82M | 173.83M | 1.04M | 156.65M |
| Foreign Exchange Rate Adjustments | 2.40M | 1.04M | 194.00K | 867.00K | -24.96M | -5.58M |
| Net Cash Flow | 211.46M | -15.48M | -55.17M | 77.26M | -129.97M | 82.99M |
| Free Cash Flow | -161.14M | -157.24M | -119.19M | -97.44M | -106.05M | -68.08M |
| Free Cash Flow Per Share | -1.48 | -1.68 | -1.77 | -1.91 | -2.50 | -1.70 |
| Levered Free Cash Flow | 249.95M | 97.14M | -66.77M | -51.00M | -72.30M | -41.51M |
| Unlevered Free Cash Flow | 253.19M | 99.96M | -63.97M | -49.62M | -72.30M | -41.51M |
| Cash Interest Paid | 3.05M | 3.05M | 3.07M | 1.25M | ||
| Cash Income Tax Paid | 755.00K | 755.00K | 1.12M | 2.44M | ||
| Change in Working Capital | 2.44M | -14.25M | 11.72M | 3.48M | -30.67M | -6.64M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.49B | 662.52M | 258.63M | 541.59M | 341.89M | 922.26M |
| Enterprise Value | 1.11B | 511.76M | 84.23M | 326.09M | 171.07M | 628.30M |
| Last Close Price | 11.57 | 6.90 | 3.78 | 8.75 | 8.03 | 22.10 |
| PB Ratio | 18.58 | -12.54 | 1.67 | 2.40 | 1.89 | 3.24 |
| P/TBV Ratio | 18.67 | 1.67 | 2.40 | 1.89 | 3.24 | |
| Debt / Equity Ratio | 0.65 | -0.66 | 0.21 | 0.15 | 0.01 | 0.01 |
| Net Debt / Equity Ratio | -4.48 | 2.17 | -0.86 | -0.83 | -0.78 | -0.95 |
| Net Debt / EBITDA Ratio | 2.04 | 0.65 | 0.85 | 1.51 | 1.48 | 3.67 |
| Net Debt / FCF Ratio | 2.35 | 0.73 | 1.11 | 1.92 | 1.33 | 3.96 |
| Quick Ratio | 1.22 | 0.67 | 5.46 | 12.71 | 10.18 | 18.83 |
| Current Ratio | 1.29 | 0.77 | 5.92 | 13.33 | 12.29 | 19.55 |
| Return on Equity (ROE) | -319.07% | -565.28% | -81.55% | -58.21% | -39.30% | -29.83% |
| Return on Assets (ROA) | -29.08% | -51.68% | -40.11% | -32.76% | -24.08% | -18.23% |
| Return on Capital Employed (ROCE) | -135.30% | 468.10% | -87.50% | -48.40% | -52.80% | -25.70% |
| Earnings Yield | -33.48% | -43.45% | -59.98% | -21.87% | -26.76% | -7.78% |
| FCF Yield | -10.21% | -23.73% | -46.08% | -17.99% | -31.02% | -7.38% |
| Buyback Yield / Dilution | -36.55% | -38.56% | -32.25% | -20.25% | -6.10% | -135.40% |